ArticleOncotarget2016

Comprehensive genetic testing identifies targetable genomic alterations in most patients with non-small cell lung cancer, specifically adenocarcinoma, single institute investigation.

Janani Vigneswaran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.